ClearSignal
ClearSignal
About ClearSignal
About ClearSignal
I’ve Been Where Your Champion Is Going. That Changes Everything.
I’ve Been Where Your Champion Is Going. That Changes Everything.
I’ve Been Where Your Champion Is Going. That Changes Everything.
I’ve Been Where Your Champion Is Going. That Changes Everything.
Most people who consult on institutional adoption understand it from the outside. They’ve studied the research, mapped the frameworks, and built the slide decks. They know the problem in theory.
Most people who consult on institutional adoption understand it from the outside. They’ve studied the research, mapped the frameworks, and built the slide decks. They know the problem in theory.
Most people who consult on institutional adoption understand it from the outside. They’ve studied the research, mapped the frameworks, and built the slide decks. They know the problem in theory.
I know it from the floor.
I know it from the floor.
I know it from the floor.
Before I was a strategist, I was a nurse… a VNA wound care nurse and an acute dialysis nurse… working in the environments where these products are meant to arrive, get used, and make a difference. I was at the very end of the adoption chain. The place where a biologic either gets picked up with confidence… or quietly set aside because the questions that mattered never got answered.
Before I was a strategist, I was a nurse… a VNA wound care nurse and an acute dialysis nurse… working in the environments where these products are meant to arrive, get used, and make a difference. I was at the very end of the adoption chain. The place where a biologic either gets picked up with confidence… or quietly set aside because the questions that mattered never got answered.
What the Floor Actually Taught Me
What the Floor Actually Taught Me
What the Floor Actually Taught Me
What the Floor Actually Taught Me
I’ve treated venous ulcers, diabetic neuropathic wounds, MASD, traumatic tissue injury… the kinds of chronic complications that don’t resolve cleanly and don’t photograph well for a clinical trial. I know what it looks like when a patient needs something better than the current standard of care.
I’ve treated venous ulcers, diabetic neuropathic wounds, MASD, traumatic tissue injury… the kinds of chronic complications that don’t resolve cleanly and don’t photograph well for a clinical trial. I know what it looks like when a patient needs something better than the current standard of care.
I’ve treated venous ulcers, diabetic neuropathic wounds, MASD, traumatic tissue injury… the kinds of chronic complications that don’t resolve cleanly and don’t photograph well for a clinical trial. I know what it looks like when a patient needs something better than the current standard of care.
And I know what it feels like to be handed a product with no clear guidance on how to use it, where to store it, or how to justify it to the person asking why it costs, what it costs.
And I know what it feels like to be handed a product with no clear guidance on how to use it, where to store it, or how to justify it to the person asking why it costs, what it costs.
And I know what it feels like to be handed a product with no clear guidance on how to use it, where to store it, or how to justify it to the person asking why it costs, what it costs.
That experience didn’t just give me clinical credibility. It gave me something more specific. I know what makes a floor nurse hesitate. I know the questions a nursing director asks before a committee ever votes. I know what “operational anxiety” actually feels like at shift change… when you’re short‑staffed and a new product shows up with a prep process nobody walked you through.
That experience didn’t just give me clinical credibility. It gave me something more specific. I know what makes a floor nurse hesitate. I know the questions a nursing director asks before a committee ever votes. I know what “operational anxiety” actually feels like at shift change… when you’re short‑staffed and a new product shows up with a prep process nobody walked you through.
That experience didn’t just give me clinical credibility. It gave me something more specific. I know what makes a floor nurse hesitate. I know the questions a nursing director asks before a committee ever votes. I know what “operational anxiety” actually feels like at shift change… when you’re short‑staffed and a new product shows up with a prep process nobody walked you through.
I’ve been the quiet no that killed a deal. Not because the product wasn’t good… but because nobody gave me what I needed to feel confident using it.
I’ve been the quiet no that killed a deal. Not because the product wasn’t good… but because nobody gave me what I needed to feel confident using it.
I’ve been the quiet no that killed a deal. Not because the product wasn’t good… but because nobody gave me what I needed to feel confident using it.
That’s not a failure of science. It’s a failure of decision support. And it’s exactly what I built ClearSignal to fix.
That’s not a failure of science. It’s a failure of decision support. And it’s exactly what I built ClearSignal to fix.
That’s not a failure of science. It’s a failure of decision support. And it’s exactly what I built ClearSignal to fix.
Where Clinical Reality Meets Commercial Strategy
Where Clinical Reality Meets Commercial Strategy
My name is Dale Hogeland, CEO & Founder of ClearSignal.
My name is Dale Hogeland, CEO & Founder of ClearSignal.
After two decades in nursing, I trained formally in B2B content strategy and copywriting under Steve Slaunwhite, and Full-Funnel Content Marketing Strategy with Russ Henneberry at AWAI. I hold degrees in Biology and Nursing, a master’s in media design, and I’ve led marketing and commercial strategy in high-stakes technical industries where the decisions carried real consequences.
After two decades in nursing, I trained formally in B2B content strategy and copywriting under Steve Slaunwhite, and Full-Funnel Content Marketing Strategy with Russ Henneberry at AWAI. I hold degrees in Biology and Nursing, a master’s in media design, and I’ve led marketing and commercial strategy in high-stakes technical industries where the decisions carried real consequences.
After two decades in nursing, I trained formally in B2B content strategy and copywriting under Steve Slaunwhite, and Full-Funnel Content Marketing Strategy with Russ Henneberry at AWAI. I hold degrees in Biology and Nursing, a master’s in media design, and I’ve led marketing and commercial strategy in high-stakes technical industries where the decisions carried real consequences.
But none of that is what makes this work different.
But none of that is what makes this work different.
But none of that is what makes this work different.
What makes it different is that I can sit across from a VP of Market Access and explain… specifically, from memory, from experience… why their champion hesitated in that room. Why the floor nurse went quiet. Why the committee tabled it again.
What makes it different is that I can sit across from a VP of Market Access and explain… specifically, from memory, from experience… why their champion hesitated in that room. Why the floor nurse went quiet. Why the committee tabled it again.
What makes it different is that I can sit across from a VP of Market Access and explain… specifically, from memory, from experience… why their champion hesitated in that room. Why the floor nurse went quiet. Why the committee tabled it again.
Not because I’ve studied it. Because I’ve lived it from the other side of the table.
Not because I’ve studied it. Because I’ve lived it from the other side of the table.
Not because I’ve studied it. Because I’ve lived it from the other side of the table.
When I audit a company's VAC materials, I'm reading them on multiple levels at once… as a strategist looking for where the decision logic breaks down, as someone trained in B2B commercial frameworks looking for where the financial case falls apart, and as the nurse who would have received those materials at the point of care, asking whether they answer the questions that actually matter when a product has to survive real clinical, operational, and financial scrutiny.
When I audit a company's VAC materials, I'm reading them on multiple levels at once… as a strategist looking for where the decision logic breaks down, as someone trained in B2B commercial frameworks looking for where the financial case falls apart, and as the nurse who would have received those materials at the point of care, asking whether they answer the questions that actually matter when a product has to survive real clinical, operational, and financial scrutiny.
When I audit a company's VAC materials, I'm reading them on multiple levels at once… as a strategist looking for where the decision logic breaks down, as someone trained in B2B commercial frameworks looking for where the financial case falls apart, and as the nurse who would have received those materials at the point of care, asking whether they answer the questions that actually matter when a product has to survive real clinical, operational, and financial scrutiny.
Why This Is Personal
Why This Is Personal
The products ClearSignal serves aren’t commodities. They restore function. They protect mobility. They improve quality of life. They help patients stay in their homes instead of moving to higher levels of care. They give clinicians a better option when standard-of-care treatments stop working.
The products ClearSignal serves aren’t commodities. They restore function. They protect mobility. They improve quality of life. They help patients stay in their homes instead of moving to higher levels of care. They give clinicians a better option when standard-of-care treatments stop working.
The products ClearSignal serves aren’t commodities. They restore function. They protect mobility. They improve quality of life. They help patients stay in their homes instead of moving to higher levels of care. They give clinicians a better option when standard-of-care treatments stop working.
When a biologic that could genuinely help people stalls in a deferral… not because the science failed, but because the decision support wasn’t there… that’s not just a commercial problem. It’s a patient problem.
When a biologic that could genuinely help people stalls in a deferral… not because the science failed, but because the decision support wasn’t there… that’s not just a commercial problem. It’s a patient problem.
When a biologic that could genuinely help people stalls in a deferral… not because the science failed, but because the decision support wasn’t there… that’s not just a commercial problem. It’s a patient problem.
I’ve sat with enough patients to know exactly what that cost looks like.
I’ve sat with enough patients to know exactly what that cost looks like.
I’ve sat with enough patients to know exactly what that cost looks like.
That’s why I do this work… because your teams need to hit their numbers, and your patients need access to what works. Those aren’t separate outcomes. When adoption stalls, both pay the price… which is exactly why my job is to make sure the right products reach the right hands before that window closes.
That’s why I do this work… because your teams need to hit their numbers, and your patients need access to what works. Those aren’t separate outcomes. When adoption stalls, both pay the price… which is exactly why my job is to make sure the right products reach the right hands before that window closes.
WHAT YOU GET WHEN YOU WORK WITH CLEARSIGNAL
WHAT YOU GET WHEN YOU WORK WITH CLEARSIGNAL
You get someone who has been inside the institution your product is trying to enter. Someone who understands the clinical language your champion speaks… and the financial language the committee demands… and knows how to bridge the two.
You get someone who has been inside the institution your product is trying to enter. Someone who understands the clinical language your champion speaks… and the financial language the committee demands… and knows how to bridge the two.
You get someone who has been inside the institution your product is trying to enter. Someone who understands the clinical language your champion speaks… and the financial language the committee demands… and knows how to bridge the two.
You get a forensic audit that finds your specific friction points that you can put into immediate action. Or if you wish, a Committee Survival Kit built to clear them. And, if you need it, ongoing vigilance to make sure your champion never walks into that room unprepared again.
You get a forensic audit that finds your specific friction points that you can put into immediate action. Or if you wish, a Committee Survival Kit built to clear them. And, if you need it, ongoing vigilance to make sure your champion never walks into that room unprepared again.
You get a forensic audit that finds your specific friction points that you can put into immediate action. Or if you wish, a Committee Survival Kit built to clear them. And, if you need it, ongoing vigilance to make sure your champion never walks into that room unprepared again.
But more than anything, you get someone who actually cares whether your innovation reaches the patients who need it.
But more than anything, you get someone who actually cares whether your innovation reaches the patients who need it.
But more than anything, you get someone who actually cares whether your innovation reaches the patients who need it.
If that’s the kind of partner you’ve been looking for, let’s talk.
If that’s the kind of partner you’ve been looking for, let’s talk.
If that’s the kind of partner you’ve been looking for, let’s talk.
Your innovation has earned a clearer path to adoption. Let's build it.
Your innovation has earned a clearer path to adoption. Let's build it.
Your innovation has earned a clearer path to adoption. Let's build it.